Learning Objective #1: state the prevalence of hyperglycemia in the total joint replacement patient population. | |||
Learning Objective #2: list effective interventions for managing hyperglycemia in the total joint replacement patient population. |
The clinical question: 1) How prevalent is hyperglycemia in the total joint replacement patient population? 2) What is the recommended glycemic range during the perioperative period? 3) Would the establishment of a standard protocol be appropriate? 4) What processes would be necessary to measure effectiveness?
Search for evidence: Included review of current literature databases (CINAHL, Medline), recommended practices (American College of Endocrinologists) and expert endocrinology consultation.
Results: Approximately 40% of patients in this study had glucose levels above the recommended range (target blood glucose is 80-110mg/dl as defined by the American College of Endocrinologists). Three of these patients were found to have undiagnosed diabetes. The results were presented at the Total Joint Replacement Center operations meeting and development of a glycemic protocol was approved. The protocol was subsequently initiated in January 2005. From January-July 2005, follow-up compliance monitoring revealed approximately 37% improvement in target blood glucose level maintenance, 17 patients with HgbA1C’s ≥ 6.7% and 6 patients newly diagnosed with diabetes mellitus.
Implications for practice: Standard protocol deemed effective for identifying the need for and management of appropriate glycemic control. Future implementations include extending the protocol to include all surgical inpatients, initiation during preadmission testing for glucose control and continued post-discharge follow-up.
See more of Poster Presentations II
See more of The 17th International Nursing Research Congress Focusing on Evidence-Based Practice (19-22 July 2006)